@article{19bf23154ee24d45b251f6306c900417,
title = "Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia",
author = "Wade Marteene and Karl Winckel and Sam Hollingworth and Steve Kisely and Erin Gallagher and Margaret Hahn and Ebdrup, {Bj{\o}rn H.} and Joseph Firth and Dan Siskind",
note = "Funding Information: DS is supported in part by an NHMRC APP1111136. D Siskind is supported in part by an NHMRC ECF APP1111136. BH Ebdrup has received lecture fees and/or is part of Advisory Boards of Bristol-Myers Squibb, Eli Lilly and Company, Janssen-Cilag, Otsuka Pharma Scandinavia AB, Takeda Pharmaceutical Company and Lundbeck Pharma A/S. MK Hahn has been on an advisory board for Alkermes. S Kisely has received speaker{\textquoteright}s honoraria from Janssen. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. Publisher Copyright: {\textcopyright} 2019, {\textcopyright} 2019 Informa UK Limited, trading as Taylor & Francis Group.",
year = "2019",
month = dec,
day = "2",
doi = "10.1080/14740338.2019.1674809",
language = "English",
volume = "18",
pages = "1149--1160",
journal = "Expert Opinion on Drug Safety",
issn = "1474-0338",
publisher = "Informa Healthcare",
number = "12",
}
